We are live on ! Find out more
REVBU

Revelation Biosciences, Inc. Unit
REVBU

Delisted

REVBU was delisted on the 11th of January, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Revelation Biosciences, Inc. Unit in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $59.9K → $0 (-$59.9K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$35.5K
2
Walleye Trading
Walleye Trading
New York
-$20.8K
3
Citadel Advisors
Citadel Advisors
Florida
-$3.46K
4
UBS Group
UBS Group
Switzerland
-$189
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
1
Walleye Capital
New York
– -$35.5K -177,428 Closed
Walleye Trading
2
Walleye Trading
New York
– -$20.8K -104,022 Closed
Citadel Advisors
3
Citadel Advisors
Florida
– -$3.46K -17,315 Closed
UBS Group
4
UBS Group
Switzerland
– -$189 -788 Closed

REVBU Hedge Fund Activity: Q1 2023 in Review

0 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q1 2023, worth a combined $0 — down 100% from $59.9K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of REVBU and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Walleye Capital, exiting entirely with an estimated $35.5K sold.

  • 0 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q1 2023, down from 4 in Q4 2022.
  • Funds reported $0 of Revelation Biosciences, Inc. Unit stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Revelation Biosciences, Inc. Unit positions in Q1 2023 and 4 closed out, a net change of -4 holders.
  • The largest Revelation Biosciences, Inc. Unit seller in Q1 2023 was Walleye Capital, an estimated $35.5K sold.

Based on aggregated 13F filings for Q1 2023.